ARTICLE | Clinical News
Teva Pharmaceuticals Industries Ltd. regulatory update
June 19, 1995 7:00 AM UTC
Teva Pharmaceuticals Industries Ltd. (TEVIY) TEVIY filed an NDA with the FDA for approval of Copaxone, Copolymer-1, to treat relapsing-remitting multiple sclerosis. Teva Marion Partners, a joint vent...